Hypertension and sexual dysfunction: Time to act

Journal of Hypertension

Volumn 29, Issue 2, 2011, Pages 403-407

  Viigimaa, Margus ^a   Doumas, Michael ^b   Vlachopoulos, Charalampos ^c   Anyfanti, Panagiota ^b   Wolf, Jacek ^d   Narkiewicz, Krzysztof ^d   Mancia, Giuseppe ^e  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEBIVOLOL; NITRIC OXIDE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL; VASODILATOR AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); COMORBIDITY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; MALE SEXUAL DYSFUNCTION; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORTALITY; ORGASM; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PENIS ERECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SYSTOLIC BLOOD PRESSURE; VISUAL DISORDER; EUROPE; FEMALE; MALE; REVIEW;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; PHOSPHODIESTERASE 5 INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SOCIETIES, MEDICAL; VASODILATOR AGENTS;

EID: 79955645434     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328342c659     Document Type: Article

References (51)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252. (Pubitemid 37553153)
2. British Hypertension Society. NICE guidelines. Hypertension. Management in adults in primary care: pharmacological update. 28 June 2006. Accessed on 17 June 2010.
3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187. (Pubitemid 46924065)
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-2158.
5. Manolis AJ, Doumas M, Viigimaa M, Narkiewitz K. Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2007;8.
6. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on impotence. J Am Med Assoc 1993;270:83-90.
7. Bachman GA, Avci D. Evaluation and management of female sexual dysfunction. Endocrinologist 2004;14:337-345. (Pubitemid 39540877)
8. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-463. (Pubitemid 30060493)
9. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(Suppl 4):S6-S11.
10. Nicolosi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003;61:201-206. (Pubitemid 36151741)
11. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544. (Pubitemid 29081307)
12. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T, GSSAB Investigators' Group. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57. (Pubitemid 40299993)
13. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223. (Pubitemid 40138015)
14. Toblli JE, Stella I, Inserra F, Ferder L, Zeller F, Mazza ON. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000;13:686-692. (Pubitemid 30459881)
15. Ushiyama M, Morita T, Kuramochi T, Yagi S, Katayama S. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 2004;27:253-261. (Pubitemid 38594397)
16. Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F, et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 2001;57:193-198. (Pubitemid 32065855)
17. Manolis A, Doumas M. Hypertension and sexual dysfunction. Arch Med Sci 2008;4:1-14.
18. Doumas M, Douma S. Sexual dysfunction in essential hypertension: myth or reality? J Clin Hypertens 2006;8:269-274.
19. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 2006;27:469-477. (Pubitemid 43667997)
20. Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A, et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 2006;24:2387-2392. (Pubitemid 44684686)
21. Subramanian S, Bopparaju S, Desai A, Wiggins T, Rambaud C, Surani S. Sexual dysfunction in women with obstructive sleep apnea. Sleep Breath 2010;14:59-62.
22. Goncalves M, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005;6:333-339. (Pubitemid 40867824)
23. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005;96:19M-23M. (Pubitemid 43017212)
24. Vlachopoulos C, Rokkas K, Ioakeimidis N, Aggeli C, Michaelides A, Roussakis G, et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol 2005;48:996-1002. (Pubitemid 41641653)
25. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007;52:1590-1600. (Pubitemid 350052419)
26. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006;27:2640-2648. (Pubitemid 44729862)
27. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360-364.
28. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996-3002. (Pubitemid 41817661)
29. Ma RC, So WY, Yang X, Yu LW, Kong AP, Ko GT, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008;51:2045-2050. (Pubitemid 351680526)
30. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008;51:2040-2044. (Pubitemid 351689055)
31. Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, et al., ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile Dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANCEND) Trials. Circulation 2010;121:1439-1446.
32. Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 2010;55:350-356.
33. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, Mugellini A. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002;58:177-180. (Pubitemid 34639571)
34. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001;14:27-31. (Pubitemid 32105914)
35. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Betablocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288:351-357. (Pubitemid 34761614)
36. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 2006;8:177-182. (Pubitemid 43349188)
37. Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 2007;34:327-331.
38. Wassertheil-Smoller S, Blaufox MD, Oberman A, Davis BR, Swencionis C, Knerr MO, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med 1991;114:613-620.
39. Kroner BA, Mulligan T, Briggs GC. Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study. Ann Pharmacother 1993;27:1329-1332. (Pubitemid 23336339)
40. Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Turner RR. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. J Hypertens 1993;11:103-113. (Pubitemid 23130561)
41. Listerri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001;321:336-341. (Pubitemid 32428834)
42. Della Chiesa A, Pfiffner D, Meier B, Hess OM. Sexual activity in hypertensive men. J Hum Hypertens 2003;17:515-521. (Pubitemid 36949446)
43. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Pressure Suppl 2003;2:29-34. (Pubitemid 38112142)
44. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J Clin Hypertens 2006;8:359-364.
45. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999;33:273-282.
46. Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman M, Mancia G. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens 2004;17:1135-1142. (Pubitemid 40029411)
47. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al., Erectile Dysfunction Guideline Update Panel. The management of erectile dysfunction: an AUA update. J Urol 2005;174:230-239.
48. Scranton RE, Lawler E, Botteman M, Chittamooru S, Gagnon D, Lew R, et al. Effect of treating erectile dysfunction on management of systolic hypertension. Am J Cardiol 2007;100:459-463. (Pubitemid 47094695)
49. McLaughlin T, Harnett J, Burhani S, Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther 2005;12:605-611. (Pubitemid 41689762)
50. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313-321. (Pubitemid 40978596)
51. Wolk R, Smith W, Neutel J, Rubino J, Xuan D, Mancuso J, et al. Blood pressure lowering effects of a new long-acting inhibitor of phosphodiesterase 5 in patients with mild to moderate hypertension. Hypertension 2009;53:1091-1097.